Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 22;23(1):452.
doi: 10.1186/s12877-023-04138-z.

Medications influencing the risk of fall-related injuries in older adults: case-control and case-crossover design studies

Yu-Seon Jung  1 , David Suh  2 , Eunyoung Kim  1 , Hee-Deok Park  1 , Dong-Churl Suh #  3 , Sun-Young Jung #  4
Affiliations

Medications influencing the risk of fall-related injuries in older adults: case-control and case-crossover design studies

Yu-Seon Jung et al. BMC Geriatr. .

Abstract

Background: Medications influencing the risk of fall-related injuries (FRIs) in older adults have been inconsistent in previous guidelines. This study employed case-control design to assess the association between FRIs and medications, and an additional case-crossover design was conducted to examine the consistency of the associations and the transient effects of the medications on FRIs.

Methods: This study was conducted using a national claims database (2002-2015) in Korea. Older adults (≥ 65 years) who had their first FRI between 2007 and 2015 were matched with non-cases in 1:2 ratio. Drug exposure was examined for 60 days prior to the date of the first FRI (index date) in the case-control design. The hazard period (1-60 days) and two control periods (121-180 and 181-240 days prior to the index date) were investigated in the case-crossover design. The risk of FRIs with 32 medications was examined using conditional logistic regression after adjusting for other medications that were significant in the univariate analysis. In the case-crossover study, the same conditional model was applied.

Results: In the case-control design, the five medications associated with the highest risk of FRIs were muscle relaxants (adjusted odd ratio(AOR) = 1.35, 95% confidence interval (CI) = 1.31-1.39), anti-Parkinson agents (AOR = 1.30, 95%CI = 1.19-1.40), opioids (AOR = 1.23, 95%CI = 1.19-1.27), antiepileptics (AOR = 1.19, 95%CI = 1.12-1.26), and antipsychotics (AOR = 1.16, 95%CI = 1.06-1.27). In the case-crossover design, the five medications associated with the highest risk of FRIs were angiotensin II antagonists (AOR = 1.87, 95%CI = 1.77-1.97), antipsychotics (AOR = 1.63, 95%CI = 1.42-1.83), anti-Parkinson agents (AOR = 1.58, 95%CI = 1.32-1.85), muscle relaxants (AOR = 1.42, 95%CI = 1.35-1.48), and opioids (AOR = 1.35, 95%CI = 1.30-1.39).

Conclusions: Anti-Parkinson agents, opioids, antiepileptics, antipsychotics, antidepressants, hypnotics and sedatives, anxiolytics, muscle relaxants, and NSAIDs/antirheumatic agents increased the risk of FRIs in both designs among older adults. Medications with a significant risk only in the case-crossover analysis, such as antithrombotic agents, calcium channel blockers, angiotensin II antagonists, lipid modifying agents, and benign prostatic hypertrophy agents, may have transient effects on FRIs at the time of initiation. Corticosteroids, which were only associated with risk of FRIs in the case-control analysis, had more of cumulative than transient effects on FRIs.

Keywords: Case-crossover; Case–control; Claims database; Fall risk-increasing drugs; Fall-related injuries.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Study design
Fig. 2
Fig. 2
Patient selection scheme
Fig. 3
Fig. 3
Risk of FRIs associated with medications from the case–control design. The odds ratio of each medication subclass was adjusted with the other 23 medication subclasses included in the model
Fig. 4
Fig. 4
Risk of FRIs associated with medications from the case-crossover design. The odds ratio of each medication was adjusted with the other 23 medications included in the model
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bergen G, Stevens MR, Burns ER. Falls and fall Injuries among adults aged ≥65 Years — United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65:993–998. doi: 10.15585/mmwr.mm6537a2. - DOI - PubMed
    1. Florence CS, et al. Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc. 2018;66:693–698. doi: 10.1111/jgs.15304. - DOI - PMC - PubMed
    1. World Health Organization . WHO Global Report on Falls Prevention in Older Age, in Geneva, Switzerland: World Health Organization. Geneva: World Health Organization; 2007.
    1. Stel VS, et al. Consequences of falling in older men and women and risk factors for health service use and functional decline. Age Ageing. 2004;33:58–65. doi: 10.1093/ageing/afh028. - DOI - PubMed
    1. de Jong M, van der Elst M, Hartholt K. Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies. Ther Adv Drug Saf. 2013;4:147–154. doi: 10.1177/2042098613486829. - DOI - PMC - PubMed

Publication types

LinkOut - more resources